PROVIDER PROFILE · NPI 1609218361
Ru-Ik CheeMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,116
Unique beneficiaries
—
Total services
16,706
Distinct HCPCS
12
Medicare payment
$1.1M
Peer benchmark
Total Medicare services vs. 1,438 Ophthalmology providers in NY — top quintile (cohort median 1,869).
PRESCRIBING · PART D · 2024
Total Rx claims
236
Beneficiaries
—
Total drug cost
$6K
Distinct drugs
6
Brand share
9.3%
Top prescribed drugs
Ketorolac Tromethamine62 claims
Brimonidine Tartrate50 claims
Dorzolamide Hcl45 claims
Prednisolone Acetate40 claims
Dorzolamide Hcl/Timolol Maleat22 claims
QUALITY · MIPS · 2024
Final MIPS score
99.4
Quality
97.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.03%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE